13743-09-4

Usage

Uses

Used in Pharmaceutical Industry:
5-PHENYL-2-METHYL-4-THIAZOLE-CARBOXYLIC ACID is used as an intermediate in the synthesis of various drugs for its potential to contribute to the development of new pharmaceuticals.
Used in Research:
5-PHENYL-2-METHYL-4-THIAZOLE-CARBOXYLIC ACID is used as a building block in the preparation of other organic compounds, facilitating the advancement of chemical research and the discovery of novel compounds with potential applications.
Used in Organic Chemistry:
5-PHENYL-2-METHYL-4-THIAZOLE-CARBOXYLIC ACID is used as a component in the synthesis of complex organic molecules, contributing to the field of organic chemistry and the creation of new chemical entities with diverse properties and functions.

Upstream product

• 133415-15-3 methyl 2-methyl-5-phenylthiazole-4-carboxylate 
• 79173-88-9 bromo-phenyl-pyruvic acid 
• 62-55-5 thioacetamide 
• 1198279-95-6 benzyl 2-methyl-5-phenylthiazole-4-carboxylate 
• 100-52-7 benzaldehyde 
• 32803-73-9 methyl 3-phenyl-3-chloro-2-ketopropionate 
• 156-06-9 2-oxo-3-(phenyl)propionic acid 

Downstream Products

• 797030-55-8 2-methylindeno[2,1-d]thiazol-4-one 
• 1097265-08-1 2-({(2S)-1-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-2-piperidinyl}methyl)-7-(trifluoromethyl)imidazo[1,2-a]pyridine 
• 1097265-10-5 2-({(2S)-1-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-2-piperidinyl}methyl)-8-(trifluoromethyl)imidazo[1,2-a]pyridine 
• 1097265-11-6 6,8-dichloro-2-({(2S)-1-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-2-piperidinyl} methyl)imidazo[1,2-a]pyridine 
• 1097265-16-1 2-({(2S)-1-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-2-piperidinyl} methyl)imidazo[1,2-a]pyridine-7-carbonitrile 
• 1097265-19-4 6-bromo-5-methyl-2-({(2S)-1-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-2-piperidinyl}methyl)imidazo[1,2-a]pyridine 
• 380899-52-5 2-methyl-5-phenyl-1,3-thiazole-4-carbonyl chloride 
• 1097265-09-2 2-({(2S)-1-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-2-piperidinyl} methyl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine 
• 1097265-18-3 2-({(2S)-1-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-2-piperidinyl}methyl)-5-(trifluoromethyl)imidazo[1,2-a]pyridine 
• 1097265-35-4 3-chloro-2-({(2S)-1-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-2-piperidinyl}methyl)imidazo[1,2-a]pyridine 
• 1097265-47-8 6-fluoro-8-methyl-2-({(2S)-1-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-2-piperidinyl}methyl)imidazo[1,2-a]pyridine 
• 1092506-43-8 {(1S,2S,5R)-3-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-3-azabicyclo[3.1.0]hex-2-yl}methanol 
• 1097180-51-2 7,8-dimethyl-2-({(2S)-1-[(2-methyl-5-phenyl-1,3-thiazol-4-yl)carbonyl]-2-piperidinyl}methyl)imidazo[1,2-c]pyrimidine 
• 1117693-65-8 {(RS)-2-Cyclopropyl-2-[methyl-(2-methyl-5-phenyl-thiazole-4-carbonyl)-amino]-ethyl}-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS

The invention relates to 1,2-diamido-ethylene derivatives of the formula (I) wherein R1, R2, R3, and A are as described in the description and their use as medicaments, especially as orexin receptor antagonists.

2-AZA-BICYCLO[3.3.0]OCTANE DERIVATIVES

The invention relates to 2-aza-bicyclo[3.3.0]octane derivatives of Formula (I) wherein A, B, and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.

SPIRO AMINO COMPOUNDS SUITABLE FOR THE TREATMENT OF INTER ALIA SLEEP DISORDERS AND DRUG ADDICTION

The invention concerns a spiro-amino compound of Formula (Vl) wherein m is 1 or 2 or 3, n is 1 or 2, R is selected from a 5- or 6-membered aromatic ring and a 5- or 6-membered heteroaromatic ring comprising 1 to 3 heteroatoms selected from S, O e N, such ring being substituted with one or two substituents selected from the group consisting of (C1-C3)alkyl, halogen, (C3-C5)cycloalkyloxy, (C1-C3)alkylcarbonyl, phenyl optionally substituted with one or more halogen atoms, a 5- or 6-membered heterocycle comprising at least one nitrogen atom; P is a substituent Q or COQ, wherein Q is selected from the group consisting of phenyl, pyridil, pyrimidil, quinolyl, isoquinolyl, quinoxalyl, benzofuranyl, imidazotriazolyl, being such Q optionally substituted with one or more substituents selected from the group consisting of (C1-C3)alkyl, halogen, trifluoromethyl, carbammido, methylcarbammido, carboxy, methylcarboxy or a pharmaceutically acceptable salt thereof.

THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS

The invention relates to thiazolidine derivatives of the formula (I) wherein A, B, and R1 are as described in the description, to salts, especially pharmaceutically acceptable salts, of such compounds and to their use as medicaments, especially

THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS

The invention relates to thiazolidine derivatives of the formula (I) wherein A, B, and R1 are as described in the description, to salts, especially pharmaceutically acceptable salts, of such compounds and to their use as medicaments, especially

THIAZOLIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

The invention relates to novel thiazolidine derivatives of the formula (I) wherein A and R1 are as described in the description and their use as medicaments, especially as orexin receptor antagonists.

AZETIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS

The invention relates to novel azetidine compounds of formula (I), wherein R1, R2, and X are as described in the description and their use as orexin receptor antagonists.

3-AZA-BICYCLO[3.3.0]OCTANE COMPOUNDS

The invention relates to 3-aza-bicyclo[3.3.0]octane derivatives of the formula (I) wherein R1, R2, R3, and A are as described in the description and their use as orexin receptor antagonists.

1,2-DIAMIDO-ETHYLENE DERIVATIVES

The invention relates to 1,2-diamido-ethylene derivatives of the formula (I) NHNR 3 OAOR 1 R 2 (I) wherein R1, R 2, R 3, and A are as described in the description and their use as medicaments, especially as orexin receptor

TRANS-3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES

The invention relates to novel trans-3-aza-bicyclo[3.1.0]hexane derivatives of formula (I), wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.